{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T05:18:05Z","timestamp":1718169485891},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.dld.2017.10.001","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T07:22:08Z","timestamp":1507965728000},"page":"96-97","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Transglutaminase 6 antibodies are not yet mainstream in neuro-coeliac disease"],"prefix":"10.1016","volume":"50","author":[{"given":"Chris J.J.","family":"Mulder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxine D.","family":"Rouvroye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"van Dam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2017.10.001_bib0005","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1212\/WNL.0b013e3182919070","article-title":"Transglutaminase 6 antibodies in the diagnosis of gluten ataxia","volume":"80","author":"Hadjivassiliou","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.dld.2017.10.001_bib0010","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"Sardy","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.dld.2017.10.001_bib0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1212\/01.wnl.0000196480.55601.3a","article-title":"Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia","volume":"66","author":"Hadjivassiliou","year":"2006","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.dld.2017.10.001_bib0020","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.dld.2017.08.019","article-title":"Transglutaminase 6 antibodies in gluten neuropathy","volume":"49","author":"Zis","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2017.10.001_bib0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1440-1789.2009.01042.x","article-title":"CD8(+)\/perforin\/granzyme B(+) effector cells infiltrating cerebellum and inferior olives in gluten ataxia","volume":"30","author":"Mittelbronn","year":"2010","journal-title":"Neuropathology"},{"key":"10.1016\/j.dld.2017.10.001_bib0030","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jamaneurol.2015.48","article-title":"Transglutaminase 6 antibodies in the serum of patients with amyotrophic lateral sclerosis","volume":"72","author":"Gadoth","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.dld.2017.10.001_bib0035","article-title":"Transglutaminase -6 is an autoantigen in progressive multiple sclerosis and is upregulated in reactive astrocytes","author":"Cristofanilli","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.dld.2017.10.001_bib0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.21324","article-title":"Fatal encephalitis in a patient with refractory celiac disease presenting with myorhythmia and carpal spasm","volume":"22","author":"Dimberg","year":"2007","journal-title":"Mov Disord"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817312525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865817312525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T20:43:12Z","timestamp":1553805792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865817312525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1590865817312525"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2017.10.001","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transglutaminase 6 antibodies are not yet mainstream in neuro-coeliac disease","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2017.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2017.08.019","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}